Why Canopy Growth (TSX:WEED) Might Not Be the Top Pot Stock for Much Longer

As well as Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has done over the years, its dominance in the industry may soon be a distant memory.

| More on:
edit Jars of marijuana

Image source: Getty Images

Canopy Growth (TSX:WEED)(NYSE:CGC) has long been known as the top cannabis stock in the world, synonymous with the industry’s growth. However, the hierarchy in the industry could soon be changing. At a market cap of more than $15 billion, Canopy Growth is certainly safe, in terms of market cap, as the top cannabis stock for the foreseeable future.

However, there’s one company that’s been making a name for itself south of the border as a formidable opponent, and one that could command significant market share in the industry. Recently, we learned that multi-state operator Curaleaf Holdings (CNSX:CURA) had acquired cannabis company Grassroots for an estimated US$875 million valuation. Throughout the past year, Curaleaf has been busy wheeling and dealing to expand its presence across the U.S.

Now, with Grassroots into the mix, Curaleaf is poised to become the largest marijuana company in the world, based on revenue. However, with a market cap of around $3.5 billion, it still has a long ways to go in rivalling Canopy Growth in terms of size. A big impediment for the company is certainly the illegality of cannabis south of the border.

Not only does that prevent Curaleaf from being able to list on major exchanges like the NYSE and TSX, but it also keeps many investors away from the stock in general. Until we see marijuana become legalized in the U.S. at the federal level, the illegality of it is always going to prevent Curaleaf from reaching a higher valuation. Trading on the Canadian Securities Exchange gives Curaleaf access to significantly fewer investors than would buy its shares if it was on the bigger exchanges.

What does this mean for cannabis investors?

Regardless of which firm is the largest in terms of market cap, what really matters is which one is the bigger brand overall. And here, Curaleaf is certainly in the pole position. Its acquisition of Grassroots will not only expand its revenues even more, but it’s a strategic move in that it will give the company an easy way to expand into some key markets.

Curaleaf will be able to increase the presence it has from 12 states to 19. The deal will give the company access to both Illinois and Michigan, two states that have recently legalized recreational marijuana. Curaleaf is going to have a big advantage on Canopy Growth by being able to tap into some lucrative pot markets, and it could be just a matter of time before the company is rewarded with a higher valuation.

Bottom line

With the departure of CEO Bruce Linton, and Canopy Growth seemingly looking for a more conventional and conservative leadership style, it’s hard to imagine a scenario where the company remains atop the industry. Curaleaf has already made a big name for itself, and it’s continuing to grow in what’s going to be a much bigger pot market than the rest of the world. U.S. pot stocks are going to see a lot more growth than their Canadian counterparts and could prove to be better investments over the long haul.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »